Looks like you’re on the UK site. Choose another location to see content specific to your location
Medtronic completes sale of business assets to Cardinal Health
Medtronic has announced the completion of the sale of selected patient monitoring and recovery assets to Cardinal Health.
The $6.1 billion (4.65 billion pounds) deal sees ownership of Medtronic's patient care, deep vein thrombosis and nutritional insufficiency businesses transfer to Cardinal Health, allowing Medtronic to focus on other areas of strategic importance.
These assets were formerly part of the patient monitoring and recovery division of Medtronic's minimally invasive therapies group. The firm retains ownership of its respiratory and monitoring solutions and renal care solutions businesses, which were part of the same portfolio.
Commenting at the time the deal was agreed, Omar Ishrak, Medtronic's chairman and chief executive officer, said: "This is a positive transaction for all involved – Medtronic, Cardinal Health and our respective shareholders and employees – who we believe will all thrive under this change in ownership."
The businesses sold to Cardinal Health generated approximately $2.4 billion in revenue over the last four reported quarters, with the transaction also including 17 dedicated manufacturing facilities.
With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips
and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard